BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salmanton-García J, Sprute R, Stemler J, Bartoletti M, Dupont D, Valerio M, Garcia-Vidal C, Falces-Romero I, Machado M, de la Villa S, Schroeder M, Hoyo I, Hanses F, Ferreira-Paim K, Giacobbe DR, Meis JF, Gangneux JP, Rodríguez-Guardado A, Antinori S, Sal E, Malaj X, Seidel D, Cornely OA, Koehler P; FungiScope European Confederation of Medical Mycology/The International Society for Human and Animal Mycology Working Group. COVID-19-Associated Pulmonary Aspergillosis, March-August 2020. Emerg Infect Dis 2021;27:1077-86. [PMID: 33539721 DOI: 10.3201/eid2704.204895] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 32.0] [Reference Citation Analysis]
Number Citing Articles
1 Bader O. Phylogenetic Distribution of csp1 Types in Aspergillus fumigatus and Their Correlates to Azole Antifungal Drug Resistance. Microbiol Spectr 2021;9:e0121421. [PMID: 34787484 DOI: 10.1128/Spectrum.01214-21] [Reference Citation Analysis]
2 Narayanan S, Chua JV, Baddley JW. COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease. Clin Infect Dis 2021:ciab726. [PMID: 34420052 DOI: 10.1093/cid/ciab726] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
3 Mitaka H, Kuno T, Takagi H, Patrawalla P. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis. Mycoses 2021;64:993-1001. [PMID: 33896063 DOI: 10.1111/myc.13292] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
4 Akhtar N, Khurshid Wani A, Kant Tripathi S, Prakash A, Amin-ul Mannan M. The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review. Current Research in Biotechnology 2022;4:337-49. [DOI: 10.1016/j.crbiot.2022.08.001] [Reference Citation Analysis]
5 Abdoli A, Falahi S, Kenarkoohi A. COVID-19-associated opportunistic infections: a snapshot on the current reports. Clin Exp Med 2021. [PMID: 34424451 DOI: 10.1007/s10238-021-00751-7] [Reference Citation Analysis]
6 Yusuf E, Seghers L, Hoek RAS, van den Akker JPC, Bode LGM, Rijnders BJA. Aspergillus in Critically Ill COVID-19 Patients: A Scoping Review. J Clin Med 2021;10:2469. [PMID: 34199528 DOI: 10.3390/jcm10112469] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Silva BRO, Rodrigues WF, Abadia DGP, Alves da Silva DA, Andrade e Silva LE, Desidério CS, Farnesi-de-assunção TS, Costa-madeira JC, Barbosa RM, Bernardes e Borges AV, Hortolani Cunha ACC, Pereira LQ, Helmo FR, Lemes MR, Barbosa LM, Trevisan RO, Obata MMS, Bueno GF, Mundim FV, Oliveira-scussel ACM, Monteiro IB, Ferreira YM, Machado GH, Ferreira-paim K, Moraes-souza H, da Silva MV, Rodrigues Júnior V, Oliveira CJF. Clinical-Epidemiology Aspect of Inpatients With Moderate or Severe COVID-19 in a Brazilian Macroregion: Disease and Countermeasures. Front Cell Infect Microbiol 2022;12:899702. [DOI: 10.3389/fcimb.2022.899702] [Reference Citation Analysis]
8 Sivasubramanian G, Ghanem H, Maison-Fomotar M, Jain R, Libke R. COVID-19-Associated Pulmonary Aspergillosis: A Single-Center Experience in Central Valley, California, January 2020-March 2021. J Fungi (Basel) 2021;7:948. [PMID: 34829235 DOI: 10.3390/jof7110948] [Reference Citation Analysis]
9 Machado M, Estévez A, Sánchez-carrillo C, Guinea J, Escribano P, Alonso R, Valerio M, Padilla B, Bouza E, Muñoz P. Incidence of Candidemia Is Higher in COVID-19 versus Non-COVID-19 Patients, but Not Driven by Intrahospital Transmission. JoF 2022;8:305. [DOI: 10.3390/jof8030305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Koehler P, White PL, Verweij PE, Cornely OA. Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis - Authors' reply. Lancet Infect Dis 2021;21:767-9. [PMID: 33662323 DOI: 10.1016/S1473-3099(21)00123-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Cimolai N. The Complexity of Co-Infections in the Era of COVID-19. SN Compr Clin Med 2021;:1-13. [PMID: 33937631 DOI: 10.1007/s42399-021-00913-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hoenigl M, Seidel D, Sprute R, Cunha C, Oliverio M, Goldman GH, Ibrahim AS, Carvalho A. COVID-19-associated fungal infections. Nat Microbiol 2022;7:1127-40. [PMID: 35918423 DOI: 10.1038/s41564-022-01172-2] [Reference Citation Analysis]
13 Meijer EFJ, Dofferhoff ASM, Hoiting O, Meis JF. COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series. Mycoses 2021;64:457-64. [PMID: 33569857 DOI: 10.1111/myc.13254] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
14 To KK, Sridhar S, Chiu KH, Hung DL, Li X, Hung IF, Tam AR, Chung TW, Chan JF, Zhang AJ, Cheng VC, Yuen KY. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microbes Infect 2021;10:507-35. [PMID: 33666147 DOI: 10.1080/22221751.2021.1898291] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
15 Etienne KA, Berkow EL, Gade L, Nunnally N, Lockhart SR, Beer K, Jordan IK, Rishishwar L, Litvintseva AP. Genomic Diversity of Azole-Resistant Aspergillus fumigatus in the United States. mBio 2021;:e0180321. [PMID: 34372699 DOI: 10.1128/mBio.01803-21] [Reference Citation Analysis]
16 Wiederhold NP. Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance. Clinical Chemistry 2022;68:83-90. [DOI: 10.1093/clinchem/hvab217] [Reference Citation Analysis]
17 Khan AA, Farooq F, Jain SK, Golinska P, Rai M. Comparative Host-Pathogen Interaction Analyses of SARS-CoV2 and Aspergillus fumigatus, and Pathogenesis of COVID-19-Associated Aspergillosis. Microb Ecol 2021. [PMID: 34738157 DOI: 10.1007/s00248-021-01913-6] [Reference Citation Analysis]
18 Rudramurthy SM, Hoenigl M, Meis JF, Cornely OA, Muthu V, Gangneux JP, Perfect J, Chakrabarti A; ECMM and ISHAM. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Mycoses 2021;64:1028-37. [PMID: 34133816 DOI: 10.1111/myc.13335] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
19 Suleyman G, Alangaden GJ. Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention. Infect Dis Clin North Am 2021;35:1027-53. [PMID: 34752219 DOI: 10.1016/j.idc.2021.08.002] [Reference Citation Analysis]
20 Giacobbe DR, Prattes J, Wauters J, Dettori S, Signori A, Salmanton-García J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, Van Regenmortel N, Lormans P, Feys S, Klimko N, Shadrivova O, Cornely OA, Rautemaa-Richardson R, Koehler P, Lagrou K, Bassetti M, Hoenigl M; ECMM-CAPA Study Group. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study. J Clin Microbiol 2022;:e0229821. [PMID: 35321555 DOI: 10.1128/jcm.02298-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Benedict K, Williams S, Beekmann SE, Polgreen PM, Jackson BR, Toda M. Testing Practices for Fungal Respiratory Infections and SARS-CoV-2 among Infectious Disease Specialists, United States. J Fungi (Basel) 2021;7:605. [PMID: 34436144 DOI: 10.3390/jof7080605] [Reference Citation Analysis]
22 White PL, Alanio A, Brown L, Cruciani M, Hagen F, Gorton R, Lackner M, Millon L, Morton CO, Rautemaa-Richardson R, Barnes RA, Donnelly JP, Loffler J; Fungal PCR Initiative. An overview of using fungal DNA for the diagnosis of invasive mycoses. Expert Rev Mol Diagn 2022. [PMID: 35130460 DOI: 10.1080/14737159.2022.2037423] [Reference Citation Analysis]
23 Burks C, Darby A, Gómez Londoño L, Momany M, Brewer MT. Azole-resistant Aspergillus fumigatus in the environment: Identifying key reservoirs and hotspots of antifungal resistance. PLoS Pathog 2021;17:e1009711. [PMID: 34324607 DOI: 10.1371/journal.ppat.1009711] [Reference Citation Analysis]
24 White PL. Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls. Curr Opin Infect Dis 2021;34:573-80. [PMID: 34751180 DOI: 10.1097/QCO.0000000000000791] [Reference Citation Analysis]
25 Saltini P, Palomba E, Castelli V, Fava M, Alagna L, Biscarini S, Mantero M, Blasi F, Grancini A, Bandera A, Gori A, Muscatello A, Lombardi A. Mucormycosis in CAPA, a Possible Fungal Super-Infection. J Fungi (Basel) 2021;7:708. [PMID: 34575746 DOI: 10.3390/jof7090708] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Jing R, Morrissey I, Xiao M, Sun T, Zhang G, Kang W, Guo D, Aram JA, Wang J, Utt EA, Wang Y, Xu Y. In vitro Activity of Isavuconazole and Comparators Against Clinical Isolates of Molds from a Multicenter Study in China. IDR 2022;Volume 15:2101-13. [DOI: 10.2147/idr.s360191] [Reference Citation Analysis]
27 Salmanton-García J, Busca A, Cornely OA, Corradini P, Hoenigl M, Klimko N, Marchesi F, Pagliuca A, Passamonti F, Koehler P, Pagano L. EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19. Hemasphere 2021;5:e612. [PMID: 34235404 DOI: 10.1097/HS9.0000000000000612] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Elbaz M, Korem M, Ayalon O, Wiener-Well Y, Shachor-Meyouhas Y, Cohen R, Bishara J, Atamna A, Brosh-Nissimov T, Maaravi N, Nesher L, Chazan B, Reisfeld S, Zimhony O, Chowers M, Maor Y, Katchman E, Ben-Ami R. Invasive Fungal Diseases in Hospitalized Patients with COVID-19 in Israel: A Multicenter Cohort Study. J Fungi (Basel) 2022;8:721. [PMID: 35887476 DOI: 10.3390/jof8070721] [Reference Citation Analysis]
29 Rizk NA, Moghnieh R, Haddad N, Rebeiz MC, Zeenny RM, Hindy JR, Orlando G, Kanj SS. Challenges to Antimicrobial Stewardship in the Countries of the Arab League: Concerns of Worsening Resistance during the COVID-19 Pandemic and Proposed Solutions. Antibiotics (Basel) 2021;10:1320. [PMID: 34827257 DOI: 10.3390/antibiotics10111320] [Reference Citation Analysis]
30 Ezeokoli OT, Gcilitshana O, Pohl CH. Risk Factors for Fungal Co-Infections in Critically Ill COVID-19 Patients, with a Focus on Immunosuppressants. J Fungi (Basel) 2021;7:545. [PMID: 34356924 DOI: 10.3390/jof7070545] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Ergün M, Brüggemann RJM, Alanio A, Dellière S, van Arkel A, Bentvelsen RG, Rijpstra T, van der Sar-van der Brugge S, Lagrou K, Janssen NAF, Buil JB, van Dijk K, Melchers WJG, Reijers MHE, Schouten JA, Wauters J, Cordey A, Soni S, White PL, van de Veerdonk FL, Verweij PE. Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients. J Clin Microbiol 2021;59:e0122921. [PMID: 34495710 DOI: 10.1128/JCM.01229-21] [Reference Citation Analysis]
32 Gudiol C, Durà-Miralles X, Aguilar-Company J, Hernández-Jiménez P, Martínez-Cutillas M, Fernandez-Avilés F, Machado M, Vázquez L, Martín-Dávila P, de Castro N, Abdala E, Sorli L, Andermann TM, Márquez-Gómez I, Morales H, Gabilán F, Ayaz CM, Kayaaslan B, Aguilar-Guisado M, Herrera F, Royo-Cebrecos C, Peghin M, González-Rico C, Goikoetxea J, Salgueira C, Silva-Pinto A, Gutiérrez-Gutiérrez B, Cuellar S, Haidar G, Maluquer C, Marin M, Pallarès N, Carratalà J. Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study. J Infect 2021;83:306-13. [PMID: 34302864 DOI: 10.1016/j.jinf.2021.07.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Kariyawasam RM, Dingle TC, Kula BE, Vandermeer B, Sligl WI, Schwartz IS. Defining COVID-19 associated pulmonary aspergillosis: systematic review and meta-analysis. Clin Microbiol Infect 2022:S1198-743X(22)00051-9. [PMID: 35150878 DOI: 10.1016/j.cmi.2022.01.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
34 Dobiáš R, Škríba A, Pluháček T, Petřík M, Palyzová A, Káňová M, Čubová E, Houšť J, Novák J, Stevens DA, Mitulovič G, Krejčí E, Hubáček P, Havlíček V. Noninvasive Combined Diagnosis and Monitoring of Aspergillus and Pseudomonas Infections: Proof of Concept. J Fungi (Basel) 2021;7:730. [PMID: 34575768 DOI: 10.3390/jof7090730] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Prattes J, Wauters J, Giacobbe DR, Salmanton-García J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, Van Regenmortel N, Lormans P, Feys S, Reisinger AC, Cornely OA, Lahmer T, Valerio M, Delhaes L, Jabeen K, Steinmann J, Chamula M, Bassetti M, Hatzl S, Rautemaa-Richardson R, Koehler P, Lagrou K, Hoenigl M; ECMM-CAPA Study Group. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect 2021:S1198-743X(21)00474-2. [PMID: 34454093 DOI: 10.1016/j.cmi.2021.08.014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 33.0] [Reference Citation Analysis]
36 Singh S, Verma N, Kanaujia R, Chakrabarti A, Rudramurthy SM. Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis. Mycoses 2021;64:1015-27. [PMID: 34057252 DOI: 10.1111/myc.13328] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Salazar F, Bignell E, Brown GD, Cook PC, Warris A. Pathogenesis of Respiratory Viral and Fungal Coinfections. Clin Microbiol Rev 2021;:e0009421. [PMID: 34788127 DOI: 10.1128/CMR.00094-21] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
38 Mirchin R, Czeresnia JM, Orner EP, Chaturvedi S, Murphy K, Nosanchuk JD. The Continuing Emergence of Candida blankii as a Pathogenic Fungus: A New Case of Fungemia in a Patient Infected with SARS-CoV-2. JoF 2022;8:166. [DOI: 10.3390/jof8020166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Hatzl S, Reisinger AC, Posch F, Prattes J, Stradner M, Pilz S, Eller P, Schoerghuber M, Toller W, Gorkiewicz G, Metnitz P, Rief M, Prüller F, Rosenkranz AR, Valentin T, Krause R, Hoenigl M, Schilcher G. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study. Crit Care 2021;25:335. [PMID: 34526087 DOI: 10.1186/s13054-021-03753-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Fischer T, El Baz Y, Graf N, Wildermuth S, Leschka S, Kleger G, Pietsch U, Frischknecht M, Scanferla G, Strahm C, Wälti S, Dietrich TJ, Albrich WC. Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis. Diagnostics 2022;12:1201. [DOI: 10.3390/diagnostics12051201] [Reference Citation Analysis]
41 Katsiari M, Mavroidi A, Palla E, Zourla K, Alonistiotis T, Ntorlis K, Nikolaou C, Vrioni G, Tsakris A. Possible COVID-19-Associated Pulmonary Aspergillosis due to Aspergillus niger in Greece. Antibiotics 2022;11:300. [DOI: 10.3390/antibiotics11030300] [Reference Citation Analysis]
42 Martins AC, Psaltikidis EM, de Lima TC, Fagnani R, Schreiber AZ, Conterno LO, Kamei K, Watanabe A, Trabasso P, Resende MR, Moretti ML. COVID-19 and invasive fungal coinfections: A case series at a Brazilian referral hospital. J Mycol Med 2021;31:101175. [PMID: 34303951 DOI: 10.1016/j.mycmed.2021.101175] [Reference Citation Analysis]
43 Roudbary M, Kumar S, Kumar A, Černáková L, Nikoomanesh F, Rodrigues CF. Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients. J Fungi (Basel) 2021;7:720. [PMID: 34575758 DOI: 10.3390/jof7090720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Jenks JD, Nam HH, Hoenigl M. Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches. Mycoses 2021;64:1002-14. [PMID: 33760284 DOI: 10.1111/myc.13274] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
45 Krishna V, Bansal N, Morjaria J, Kaul S. COVID-19-Associated Pulmonary Mucormycosis. JoF 2022;8:711. [DOI: 10.3390/jof8070711] [Reference Citation Analysis]
46 Ranhel D, Ribeiro A, Batista J, Pessanha M, Cristovam E, Duarte A, Dias A, Coelho L, Monteiro F, Freire P, Veríssimo C, Sabino R, Toscano C. COVID-19-Associated Invasive Pulmonary Aspergillosis in the Intensive Care Unit: A Case Series in a Portuguese Hospital. J Fungi (Basel) 2021;7:881. [PMID: 34682302 DOI: 10.3390/jof7100881] [Reference Citation Analysis]
47 White PL, Springer J, Wise MP, Einsele H, Löffler C, Seif M, Prommersberger S, Backx M, Löffler J. A Clinical Case of COVID-19-Associated Pulmonary Aspergillosis (CAPA), Illustrating the Challenges in Diagnosis (Despite Overwhelming Mycological Evidence). JoF 2022;8:81. [DOI: 10.3390/jof8010081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Basile K, Halliday C, Kok J, Chen SC. Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients. JoF 2022;8:58. [DOI: 10.3390/jof8010058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
49 Shadrivova O, Gusev D, Vashukova M, Lobzin D, Gusarov V, Zamyatin M, Zavrazhnov A, Mitichkin M, Borzova Y, Kozlova O, Desyatik E, Burygina E, Ignatyeva S, Oganesyan E, Vasilyeva N, Klimko N, Working Group. COVID-19-Associated Pulmonary Aspergillosis in Russia. J Fungi (Basel) 2021;7:1059. [PMID: 34947041 DOI: 10.3390/jof7121059] [Reference Citation Analysis]
50 Jalodia R, Antoine D, Braniff RG, Dutta RK, Ramakrishnan S, Roy S. Opioid-Use, COVID-19 Infection, and Their Neurological Implications. Front Neurol 2022;13:884216. [DOI: 10.3389/fneur.2022.884216] [Reference Citation Analysis]
51 Vanbellinghen MC, Atasever B, van der Spoel HJI, Bouman CCS, Altenburg J, van Dijk K. Mini-Bronchoalveolar Lavage for Diagnosing Coronavirus Disease 2019-Associated Invasive Pulmonary Aspergillosis. Crit Care Explor 2021;3:e0601. [PMID: 34939036 DOI: 10.1097/CCE.0000000000000601] [Reference Citation Analysis]
52 Seidel D, Simon M, Sprute R, Lubnow M, Evert K, Speer C, Seeßle J, Khatamzas E, Merle U, Behrens C, Blau IW, Enghard P, Haas CS, Steinmann J, Kurzai O, Cornely OA. Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals. Mycoses 2021. [PMID: 34655486 DOI: 10.1111/myc.13379] [Reference Citation Analysis]
53 van de Veerdonk FL, Brüggemann RJM, Vos S, De Hertogh G, Wauters J, Reijers MHE, Netea MG, Schouten JA, Verweij PE. COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion. Lancet Respir Med 2021;9:795-802. [PMID: 34051176 DOI: 10.1016/S2213-2600(21)00138-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Chen Y, Lin Y, Kuo S, Lee C. Air Sampling for Fungus around Hospitalized Patients with Coronavirus Disease 2019. JoF 2022;8:692. [DOI: 10.3390/jof8070692] [Reference Citation Analysis]
55 Ullah N, Sepulcri C, Mikulska M. Isavuconazole for COVID-19-Associated Invasive Mold Infections. JoF 2022;8:674. [DOI: 10.3390/jof8070674] [Reference Citation Analysis]
56 Rafiq M, Rivieccio F, Zimmermann AK, Visser C, Bruch A, Krüger T, González Rojas K, Kniemeyer O, Blango MG, Brakhage AA. PLB-985 Neutrophil-Like Cells as a Model To Study Aspergillus fumigatus Pathogenesis. mSphere 2022;:e0094021. [PMID: 34986319 DOI: 10.1128/msphere.00940-21] [Reference Citation Analysis]
57 Kula BE, Clancy CJ, Hong Nguyen M, Schwartz IS. Invasive mould disease in fatal COVID-19: a systematic review of autopsies. Lancet Microbe 2021;2:e405-14. [PMID: 34189490 DOI: 10.1016/S2666-5247(21)00091-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
58 Osaigbovo II, Bongomin F. Point of care tests for invasive fungal infections: a blueprint for increasing availability in Africa. Ther Adv Infect Dis 2021;8:20499361211034266. [PMID: 34422265 DOI: 10.1177/20499361211034266] [Reference Citation Analysis]
59 Brackin AP, Hemmings SJ, Fisher MC, Rhodes J. Fungal Genomics in Respiratory Medicine: What, How and When? Mycopathologia 2021;186:589-608. [PMID: 34490551 DOI: 10.1007/s11046-021-00573-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Borman AM, Fountain H, Guy R, Casale E, Gerver SM, Elgohari S, Brown CS, Hopkins S, Chalker VJ, Johnson EM. Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England. J Infect 2022:S0163-4453(21)00665-4. [PMID: 34995636 DOI: 10.1016/j.jinf.2021.12.047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Baddley JW, Thompson GR 3rd, Chen SC, White PL, Johnson MD, Nguyen MH, Schwartz IS, Spec A, Ostrosky-Zeichner L, Jackson BR, Patterson TF, Pappas PG. Coronavirus Disease 2019-Associated Invasive Fungal Infection. Open Forum Infect Dis 2021;8:ofab510. [PMID: 34877364 DOI: 10.1093/ofid/ofab510] [Reference Citation Analysis]
62 Hoenigl M, Egger M, Boyer J, Schulz E, Prattes J, Jenks JD. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study. Mycoses 2021. [PMID: 34252244 DOI: 10.1111/myc.13352] [Reference Citation Analysis]
63 Baddley JW. COVID-19 Associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes? Clin Infect Dis 2021:ciab259. [PMID: 33754152 DOI: 10.1093/cid/ciab259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Verweij PE, Brüggemann RJM, Azoulay E, Bassetti M, Blot S, Buil JB, Calandra T, Chiller T, Clancy CJ, Cornely OA, Depuydt P, Koehler P, Lagrou K, de Lange D, Lass-Flörl C, Lewis RE, Lortholary O, Liu PL, Maertens J, Nguyen MH, Patterson TF, Rijnders BJA, Rodriguez A, Rogers TR, Schouten JA, Wauters J, van de Veerdonk FL, Martin-Loeches I. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med 2021;47:819-34. [PMID: 34160631 DOI: 10.1007/s00134-021-06449-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Schwarz P, Nikolskiy I, Bidaud A, Sommer F, Bange G, Dannaoui E. In Vitro Activity of Amphotericin B in Combination with Colistin against Fungi Responsible for Invasive Infections. JoF 2022;8:115. [DOI: 10.3390/jof8020115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Prattes J, Wauters J, Giacobbe DR, Lagrou K, Hoenigl M; ECMM-CAPA Study Group. Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive Care Med 2021. [PMID: 34269853 DOI: 10.1007/s00134-021-06471-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
67 Gamon E, Tammena D, Wattenberg M, Augenstein T. [Rare superinfection in a COVID-19 patient-A chronology]. Anaesthesist 2021. [PMID: 34427689 DOI: 10.1007/s00101-021-01018-2] [Reference Citation Analysis]
68 Basu A. In Silico Epitope-Based Vaccine Prediction against Fungal Infection Aspergillosis. Challenges 2022;13:29. [DOI: 10.3390/challe13020029] [Reference Citation Analysis]
69 Guemas E, Cassaing S, Malavaud S, Fillaux J, Chauvin P, Lelièvre L, Ruiz S, Riu B, Berry A, Iriart X. A Clustered Case Series of Mucorales Detection in Respiratory Samples from COVID-19 Patients in Intensive Care, France, August to September 2021. JoF 2022;8:258. [DOI: 10.3390/jof8030258] [Reference Citation Analysis]
70 Apostolopoulou A, Clancy CJ, Skeel A, Nguyen MH. Invasive Pulmonary Aspergillosis Complicating Noninfluenza Respiratory Viral Infections in Solid Organ Transplant Recipients. Open Forum Infect Dis 2021;8:ofab478. [PMID: 34805426 DOI: 10.1093/ofid/ofab478] [Reference Citation Analysis]
71 Rouzé A, Lemaitre E, Martin-Loeches I, Povoa P, Diaz E, Nyga R, Torres A, Metzelard M, Du Cheyron D, Lambiotte F, Tamion F, Labruyere M, Boulle Geronimi C, Luyt CE, Nyunga M, Pouly O, Thille AW, Megarbane B, Saade A, Magira E, Llitjos JF, Ioannidou I, Pierre A, Reignier J, Garot D, Kreitmann L, Baudel JL, Voiriot G, Plantefeve G, Morawiec E, Asfar P, Boyer A, Mekontso-Dessap A, Makris D, Vinsonneau C, Floch PE, Marois C, Ceccato A, Artigas A, Gaudet A, Nora D, Cornu M, Duhamel A, Labreuche J, Nseir S; coVAPid study group. Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study. Crit Care 2022;26:11. [PMID: 34983611 DOI: 10.1186/s13054-021-03874-1] [Reference Citation Analysis]
72 Borman AM, Fraser M, Patterson Z, McLachlan S, Palmer MD, Mann C, Oliver D, Brown P, Linton CJ, Dzietczyk A, Hedley M, Gough M, Johnson EM. The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload. Med Mycol 2021:myab039. [PMID: 34259872 DOI: 10.1093/mmy/myab039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Hashim Z, Neyaz Z, Marak RSK, Nath A, Nityanand S, Tripathy NK. Practice Guidelines for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis in an Intensive Care Setting. J Intensive Care Med 2021;:8850666211047166. [PMID: 34678103 DOI: 10.1177/08850666211047166] [Reference Citation Analysis]
74 Jabeen K, Farooqi J, Irfan M, Ali SA, Denning DW. Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis. Lancet Infect Dis 2021;21:767. [PMID: 33662326 DOI: 10.1016/S1473-3099(21)00066-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]